By Professor David Lawson Morris

Journal articles

Chua TC; Al-Zahrani A; Saxena A; Glenn DW; Liauw W; Zhao J; Morris DL, 2011, 'Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.', Annals of Surgical Oncology, 18, pp. 1582 - 1589, http://dx.doi.org/10.1245/s10434-010-1492-3

Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL, 2011, 'Evolution of locoregional treatment for peritoneal carcinomatosis: Single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy', American Journal of Surgery, 201, pp. 149 - 156, http://dx.doi.org/10.1016/j.amjsurg.2010.02.012

Chua TC; Saxena A; Liauw W; Chu F; Morris DL, 2011, 'Hepatic resection for metastatic breast cancer: A systematic review', European Journal of Cancer, 47, pp. 2282 - 2290, http://dx.doi.org/10.1016/j.ejca.2011.06.024

Chua TC; Saxena A; Chu F; Butler P; Quinn RJ; Glenn DW; Morris DL, 2011, 'Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma - A comparative analysis', International Journal of Clinical Oncology, 16, pp. 125 - 132, http://dx.doi.org/10.1007/s10147-010-0143-9

Saxena A; Chua TC; Chu F; Morris DL, 2011, 'Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival', American Journal of Surgery, 202, pp. 310 - 320, http://dx.doi.org/10.1016/j.amjsurg.2010.08.041

Saxena A; Chua TC; Morris DL, 2011, 'In Reply: Pseudomyxoma peritonei: Debulk or maximal cytoreduction?', Annals of Surgical Oncology, 18, pp. 284 - 285, http://dx.doi.org/10.1245/s1034-010-1194-x

Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher A; Pelz J, 2011, 'Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study', Annals of Surgical Oncology, 18, pp. 1560 - 1567, http://dx.doi.org/10.1245/s10434-010-1522-1

Chua TC; Chu F; Morris DL, 2011, 'Outcomes of Single-Centre Experience of Hepatic Resection and Cryoablation of Sarcoma Liver Metastases', American Journal of Clinical Oncology - Cancer Clinical Trials, 34, pp. 317 - 320, http://dx.doi.org/10.1097/COC.0b013e3181e1d078

Pillai K; Akhter J; Pourgholami MH; Morris DL, 2011, 'Peritoneal mesothelioma in a woman who has survived for seven years : A case report', Journal of Medical Case Reports, 5:36, pp. 1 - 4, http://dx.doi.org/10.1186/1752-1947-5-36

Chua TC; Saxena A; Chu F; Zhao J; Morris DL, 2011, 'Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10- year survivors', Journal of Surgical Oncology, 103, pp. 796 - 800, http://dx.doi.org/10.1002/jso.21864

Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL, 2011, 'Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach', Surgery, 149, pp. 209 - 220, http://dx.doi.org/10.1016/j.surg.2010.06.008

Chua TC; Bester L; Saxena A; Morris DL, 2011, 'Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases', Journal of Cancer Research and Clinical Oncology, 137, pp. 865 - 873, http://dx.doi.org/10.1007/s00432-010-0948-y

Morris DL; Chua TC, 2011, 'Reply - Refers to:Is Malignant Dedifferentiation for Mucinous Appendiceal Neoplasms a Valid Phenomenon or Merely Histopathologic Ambiguity?', Journal of the American College of Surgeons, 212, pp. 907 - 907, http://dx.doi.org/10.1016/j.jamcollsurg.2011.02.001

Chua TC; Al-Alem I; Saxena A; Liauw W; Morris DL, 2011, 'Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: An evaluation of 46 consecutive patients.', Annals of Surgical Oncology, 18, pp. 1540 - 1546, http://dx.doi.org/10.1245/s10434-011-1714-3

Saxena A; Chua TC; Morris DL, 2011, 'Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer', Annals of Surgical Oncology, 18, pp. s222 - s223, http://dx.doi.org/10.1245/s10434-010-1342-3

Chua TC; Crowe PJ; Morris DL, 2011, 'Trends in surgical oncology research in Australia during the period 1998-2009-a bibliometric review.', Journal of Surgical Oncology, 104, pp. 216 - 219, http://dx.doi.org/10.1002/jso.21942

Pourgholami MH; Morris DL; Stenzel M; Kim Y, 2011, 'Triggering the fast release of drugs from crosslinked micelles in an acidic environment', Journal of Materials Chemistry, 21, pp. 12777 - 12783, http://dx.doi.org/10.1039/c1jm11062d

Chua TC; Liauw W; Zhao J; Morris DL, 2011, 'Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate', Annals of Surgery, 253, pp. 769 - 773, http://dx.doi.org/10.1097/SLA.0b013e31820b4dba

Chua TC; Crowe PJ; Morris DL, 2011, 'Whither surgical oncology?', ANZ Journal of Surgery, 81, pp. 763 - 764, http://dx.doi.org/10.1111/j.1445-2197.2011.05875.x

Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ, 2010, 'Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus', European Journal of Human Genetics, 18, pp. 1027 - 1031, http://dx.doi.org/10.1038/ejhg.2010.56

Yan TD; Sugarbaker PH; Elias D; Glehen O; Levine EA; Moran BJ; Deraco M; Morris DL; Piso P, 2010, 'Reply to M. Markman', Journal of Clinical Oncology, 28, http://dx.doi.org/10.1200/JCO.2010.29.1138

Cao C; Yan TD; Morris DL; Bester L, 2010, 'Radioembolization with Yttrium-90 Microspheres for Pancreatic Cancer Liver Metastases: Results from a Pilot Study', Tumori Journal, 96, pp. 955 - 958, http://dx.doi.org/10.1700/548.6515

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j.ejso.2009.06.008

Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8

Feehally J; Farrall M; Boland A; Gale DP; Gut I; Heath S; Kumar A; Peden JF; Maxwell PH; Morris DL; Padmanabhan S; Vyse TJ; Zawadzka A; Rees AJ; Lathrop M; Ratcliffe PJ, 2010, 'HLA has strongest association with IgA nephropathy in genome-wide analysis', Journal of the American Society of Nephrology, 21, pp. 1791 - 1797, http://dx.doi.org/10.1681/ASN.2010010076

Saxena A; Yan TD; Morris DL, 2010, 'A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis', World Journal of Surgery, 34, pp. 70 - 78, http://dx.doi.org/10.1007/s00268-009-0206-0

Esquivel J; Chua TC; Stojadinovic A; Melero JT; Levine E; Gutman M; Howard R; Piso P; Nissan A; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Shen P; Stewart J; Sugarbaker PH; Barone R; Hoefer R; Morris DL; Sardi A; Sticca R, 2010, 'Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi-institutional study', Journal of Surgical Oncology, 102, pp. 565 - 570, http://dx.doi.org/10.1002/jso.21601

Pourgholami MH; Khachigian LM; Fahmy R; Badar S; Wang L; Chu SW; Morris DL, 2010, 'Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis', Biochemical and Biophysical Research Communications, 397, pp. 729 - 734, http://dx.doi.org/10.1016/j.bbrc.2010.06.019

Saxena A; Chua TC; Sarkar A; Chu F; Morris DL, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic reseciton of intrahepatic cholangiocarcinoma: A 19-year experience from an Established Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1128 - 1138, http://dx.doi.org/10.1007/s11605-010-1203-1

Chua TC; Saxena A; Chu F; Liauw WS; Zhao J; Morris DL, 2010, 'Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients - Experience from an Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1370 - 1380, http://dx.doi.org/10.1007/s11605-010-1277-9

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j-ejso.2009.06.008

Saxena A; Yan TD; Chua TC; Morris DL, 2010, 'Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', Annals of Surgical Oncology, 17, pp. 1291 - 1301, http://dx.doi.org/10.1245/s10434-009-0875-9

Zhao Y; Pourgholami MH; Morris DL; Collins JG; Day AI, 2010, 'Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril', Organic and Biomolecular Chemistry, 8, pp. 3328 - 3337, http://dx.doi.org/10.1039/c003732j

Pelz J; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Maeder U; Germer CT; Kerscher A, 2010, 'Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.', BMC Cancer, 10:689, pp. 1 - 12, http://dx.doi.org/10.1186/1471-2407-10-689

Chua TC; Martin S; Saxena A; Liauw WS; Yan TD; Zhao J; Lok I; Morris DL, 2010, 'Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (Peritonectomy) at the St George Hospital peritoneal surface malignancy program', Annals of Surgery, 251, pp. 323 - 329, http://dx.doi.org/10.1097/SLA.0b013e3181c9b53c

Chua TC; Glenn DW; Morris DL, 2010, 'Extending the survival of patients with melanoma lung metastases through radiofrequency ablation', ACTA Oncologica, 49, pp. 517 - 519, http://dx.doi.org/10.3109/02841860903473305

Saxena A; Chua TC; Bester L; Kokandi A; Morris DL, 2010, 'Factors predicting response and survival after Yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: A critical appraisal of 48 cases', Annals of Surgery, 251, pp. 910 - 916, http://dx.doi.org/10.1097/SLA.0b013e3181d3d24a

Yao P; Stanton R; Chua TC; Wines MP; Gunasegaram A; Ladd LA; Morris DL, 2010, 'Hand-assisted laparoscopic partial nephrectomy: A controlled study of bipolar InLine radiofrequency ablation device in swine', Surgical Innovation, 17, pp. 57 - 62, http://dx.doi.org/10.1177/1553350609360354

Ding JH; Chua TC; Al-Mohaimeed K; Morris DL, 2010, 'Hepatocellular carcinoma peritoneal metastases: Report of three cases and collective review of the literature', Annals of Academy of Medicine Singapore, 39, pp. 734 - 737

Chua TC; Morris DL; Esquivel J, 2010, 'Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy', Annals of Surgical Oncology, 17, pp. 1330 - 1336, http://dx.doi.org/10.1245/s10434-009-0866-x

Chua TC; Yao P; Akhter J; Morris DL, 2010, 'Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy', Pathology and Oncology Research, 16, pp. 217 - 222, http://dx.doi.org/10.1007/s12253-009-9210-9

Chua TC; Chu F; Butler P; Quinn RJ; Glenn DW; Liauw WS; Morris DL, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', Cancer, 116, pp. 4069 - 4077, http://dx.doi.org/10.1002/cncr.25283

Chua TC; Sarkar A; Saxena A; Glenn DW; Zhao J; Morris DL, 2010, 'Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.', Annals of Oncology, 21, pp. 2017 - 2022, http://dx.doi.org/10.1093/annonc/mdq098

Chua TC; Saxena A; Schellekens J; Liauw WS; Yan TD; Fransi S; Zhao J; Morris DL, 2010, 'Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: Towards a new perspective of this treatment.', Annals of Surgical Oncology, 251, pp. 101 - 106, http://dx.doi.org/10.1097/SLA.0b013e3181b5ae43

Mekkawy AH; De Bock CE; Lin Z; Morris DL; Wang Y; Pourgholami MH, 2010, 'Novel protein interactors of urokinase-type plasminogen activator receptor', Biochemical and Biophysical Research Communications, 399, pp. 738 - 743, http://dx.doi.org/10.1016/j.bbrc.2010.08.010

Chua TC; Yan TD; Zhao J; Morris DL, 2010, 'Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy', American Journal of Clinical Oncology - Cancer Clinical Trials, 33, pp. 568 - 571, http://dx.doi.org/10.1097/COC.0b013e3181b9cf47

Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8

Saxena A; Chua TC; Yan TD; Morris DL, 2010, 'Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: Incidence, risk factors, management, and clinical sequelae', Annals of Surgical Oncology, 17, pp. 1302 - 1310, http://dx.doi.org/10.1245/s10434-009-0898-2

Pourgholami MH; Cai YZ; Badar S; Wangoo K; Poruchynsky MS; Morris DL, 2010, 'Potent inhibition of tumoral hypoxia-inducible factor 1á by albendazole.', BMC Cancer, 10:143, pp. 1 - 7, http://dx.doi.org/10.1186/1471-2407-10-143

Cao C; Yan TD; Bester L; Liauw WS; Morris DL, 2010, 'Radioembolization with yttrium micropheres for neuroendocrine tumour liver metastases', British Journal of Surgery, 97, pp. 537 - 543, http://dx.doi.org/10.1002/bjs.6931

Back to profile page